share_log

Is Boai NKY Medical Holdings (SZSE:300109) Using Too Much Debt?

Is Boai NKY Medical Holdings (SZSE:300109) Using Too Much Debt?

新开源医疗控股(SZSE:300109)是否使用过多的债务?
Simply Wall St ·  2024/12/31 08:44

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. We note that Boai NKY Medical Holdings Ltd. (SZSE:300109) does have debt on its balance sheet. But the more important question is: how much risk is that debt creating?

大卫·伊本说得很好:'波动性不是我们关心的风险。我们关心的是避免资本的永久损失。' 所以聪明的钱知道,债务——通常与破产有关——是评估一家公司风险时非常重要的因素。我们注意到,新开源医疗控股有限公司(SZSE:300109)确实在其资产负债表上有债务。但更重要的问题是:这些债务创造了多少风险?

When Is Debt A Problem?

何时债务成为问题?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Of course, plenty of companies use debt to fund growth, without any negative consequences. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

一般来说,债务只有在公司无法轻松偿还时才会成为真正的问题,要么通过融资,要么通过自身的现金流。如果情况变得非常糟糕,贷款人可以控制业务。虽然这种情况并不太常见,但我们常常看到负债公司因贷款人迫使他们以低价融资而永久稀释股东的股份。当然,很多公司利用债务来支持增长,没有任何负面影响。在考虑一家企业使用多少债务时,首先要查看其现金和债务的组合。

What Is Boai NKY Medical Holdings's Debt?

新开源医疗控股有限公司的债务是多少?

The image below, which you can click on for greater detail, shows that at September 2024 Boai NKY Medical Holdings had debt of CN¥405.4m, up from CN¥70.8m in one year. On the flip side, it has CN¥322.0m in cash leading to net debt of about CN¥83.4m.

下图,您可以点击查看更详细信息,显示到2024年9月,新开源医疗控股有限公司的债务为40540万CN¥,相比去年7080万CN¥有所增加。相反,它有32200万CN¥的现金,导致净债务约为8340万CN¥。

big
SZSE:300109 Debt to Equity History December 31st 2024
SZSE:300109 债务与权益历史 2024年12月31日

How Strong Is Boai NKY Medical Holdings' Balance Sheet?

新开源医疗控股的资产负债表有多强?

The latest balance sheet data shows that Boai NKY Medical Holdings had liabilities of CN¥613.4m due within a year, and liabilities of CN¥204.7m falling due after that. Offsetting this, it had CN¥322.0m in cash and CN¥487.0m in receivables that were due within 12 months. So its total liabilities are just about perfectly matched by its shorter-term, liquid assets.

最新的资产负债表数据显示,新开源医疗控股有限公司的流动负债为61340万元,1年内到期的流动负债为20470万元。对此,它有32200万元的现金和48700万元的应收账款到期在12个月内。因此,它的总负债几乎完全与其短期的流动资产相匹配。

Having regard to Boai NKY Medical Holdings' size, it seems that its liquid assets are well balanced with its total liabilities. So while it's hard to imagine that the CN¥8.16b company is struggling for cash, we still think it's worth monitoring its balance sheet. But either way, Boai NKY Medical Holdings has virtually no net debt, so it's fair to say it does not have a heavy debt load!

考虑到新开源医疗控股有限公司的规模,它的流动资产与总负债之间的平衡似乎很好。因此,虽然很难想象这家81.6亿元的公司在资金上会有困难,但我们仍然认为监控其资产负债表是值得的。但是无论如何,新开源医疗控股有限公司几乎没有净债务,因此可以公平地说它并没有重负债!

We measure a company's debt load relative to its earnings power by looking at its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and by calculating how easily its earnings before interest and tax (EBIT) cover its interest expense (interest cover). Thus we consider debt relative to earnings both with and without depreciation and amortization expenses.

我们通过查看公司的净负债与息税折旧摊销前利润(EBITDA)的比例来衡量公司相对于其收益能力的债务负担,以及计算其息税前利润(EBIT)覆盖利息支出的能力(利息覆盖率)。因此,我们在考虑收益时同时考虑了折旧与摊销费用及不考虑这些费用的情况。

Boai NKY Medical Holdings has net debt of just 0.17 times EBITDA, suggesting it could ramp leverage without breaking a sweat. And remarkably, despite having net debt, it actually received more in interest over the last twelve months than it had to pay. So it's fair to say it can handle debt like a hotshot teppanyaki chef handles cooking. But the bad news is that Boai NKY Medical Holdings has seen its EBIT plunge 20% in the last twelve months. If that rate of decline in earnings continues, the company could find itself in a tight spot. When analysing debt levels, the balance sheet is the obvious place to start. But it is Boai NKY Medical Holdings's earnings that will influence how the balance sheet holds up in the future. So if you're keen to discover more about its earnings, it might be worth checking out this graph of its long term earnings trend.

新开源医疗控股有限公司的净债务仅为EBITDA的0.17倍,这表明它在杠杆方面可以轻松提高。值得注意的是,尽管有净债务,但在过去的12个月里,它所收到的利息实际上超过了它需要支付的利息。因此,可以公平地说它处理债务的能力就像一位出色的铁板烧厨师处理烹饪一样。不过坏消息是,新开源医疗控股有限公司的EBIT在过去12个月中暴跌了20%。如果这种收益下降的趋势继续下去,公司可能会面临困境。在分析债务水平时,资产负债表显然是一个明显的起点。但使新开源医疗控股有限公司能否维持资产负债表的关键因素将是其未来的收益。所以如果你想了解更多关于其收益的信息,查看其长期收益趋势的图表可能是值得的。

Finally, a business needs free cash flow to pay off debt; accounting profits just don't cut it. So we clearly need to look at whether that EBIT is leading to corresponding free cash flow. Over the last three years, Boai NKY Medical Holdings barely recorded positive free cash flow, in total. While many companies do operate at break-even, we prefer see substantial free cash flow, especially if a it already has dead.

最后,业务需要自由现金流来偿还债务;账面利润根本无法满足这一需求。因此,我们显然需要查看EBIt是否导致相应的自由现金流。在过去三年中,新开源医疗控股公司的自由现金流几乎没有记录为正数。虽然许多公司确实处于盈亏平衡状态,但我们更倾向于看到可观的自由现金流,特别是当它已经有死损失时。

Our View

我们的观点

While Boai NKY Medical Holdings's EBIT growth rate has us nervous. For example, its interest cover and net debt to EBITDA give us some confidence in its ability to manage its debt. We think that Boai NKY Medical Holdings's debt does make it a bit risky, after considering the aforementioned data points together. Not all risk is bad, as it can boost share price returns if it pays off, but this debt risk is worth keeping in mind. There's no doubt that we learn most about debt from the balance sheet. But ultimately, every company can contain risks that exist outside of the balance sheet. For instance, we've identified 2 warning signs for Boai NKY Medical Holdings that you should be aware of.

虽然新开源医疗控股公司的EBIt增长率让我们感到紧张。例如,它的利息覆盖率和净债务与EBITDA的比率让我们对其管理债务的能力有一些信心。在综合考虑上述数据后,我们认为新开源医疗控股公司的债务确实让其有一些风险。并不是所有风险都是坏事,因为如果它获利,可能会提高股票价格的回报,但这种债务风险值得牢记。毫无疑问,我们从资产负债表中可以了解到大部分债务。但是最终,每个公司都可能存在资产负债表外的风险。例如,我们已经为新开源医疗控股公司识别出了2个警告信号,你应该注意。

Of course, if you're the type of investor who prefers buying stocks without the burden of debt, then don't hesitate to discover our exclusive list of net cash growth stocks, today.

当然,如果你是那种喜欢购买没有债务负担的股票的投资者,那么不要犹豫,今天就来发现我们独家的净现金成长股票列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有反馈?对内容有疑虑?请直接与我们联系。或者,发送电子邮件至 editorial-team (at) simplywallst.com。
这篇来自Simply Wall St的文章是一般性的。我们根据历史数据和分析师预测提供评论,采用无偏见的方法,我们的文章并不旨在提供财务建议。它不构成对任何股票的买入或卖出建议,也未考虑到您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发